Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 76282-677

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 76282-677). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (531075c8 2fa1 4061 Adf9 F8e64ccde1e2 01)

Chemical structure diagram of Emtricitabine, showing the molecular arrangement with nitrogen, oxygen, fluorine atoms, and a sulfur-containing ring.*

FDA Label Image

Image (531075c8 2fa1 4061 Adf9 F8e64ccde1e2 02)

Chemical structure of emtricitabine and tenofovir disoproxil fumarate, the active ingredients in this combination drug product.*

FDA Label Image

30 Tablets (531075c8 2fa1 4061 Adf9 F8e64ccde1e2 03)

Label for Emtricitabine and Tenofovir Disoproxil Fumarate tablets, film coated, with strengths of 200 mg and 300 mg per tablet. The label states the medication is for oral use and indicates the package contains 30 tablets. It is manufactured by Exelan Pharmaceuticals, Inc., with an NDC of 76282-677. The label includes dosing specifics, storage instructions, and a pharmacist dispensing note. The product is marked Rx only and child-resistant packaging is noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.